ABEV ABEV
Company Profile ↓Company Overview
ABEV (ABEV) is a publicly traded company listed on with a market capitalization of $47.76B. The valuation, growth and price-trend signals below summarize what matters most to investors and traders evaluating the stock.
Why Investors Should Care
Generates a return on equity of 17.6%, reflecting efficient use of shareholder capital.
Return on capital employed stands at 22.4%.
Trades at an undemanding P/E of 3.1.
Maintains a net profit margin of 17.6%.
Generates positive free cash flow, funding growth and shareholder returns internally.
Recent Developments
- Dec 2025 Revenue of $88.24B (-1.4% YoY); net profit $15.50B.
- Trailing 12 Months Year-on-year growth — revenue -1.4%, earnings +7.4%.
- 5-Year Trend Long-term compounding — revenue CAGR 3.4%, profit CAGR 2.4%.
Growth & Price Performance
Compounded Sales Growth
| 5 Years: | 3.45% |
| 1 Year: | -1.35% |
Compounded Profit Growth
| 5 Years: | 2.35% |
| 1 Year: | 7.39% |
Stock Price Performance
| 1 Year: | +38.91% |
| 6 Months: | +4.78% |
| 3 Months: | -9.83% |
| 1 Month: | +1.00% |
Highlights auto-generated from reported financials and price data; not investment advice. Verify with official filings before acting.
- Price vs 50-DMABelow
- Price vs 200-DMAAbove
- RSI (14)42.91 · Neutral
Auto-generated from price history and fundamentals; not investment advice.
Price Chart
Technical Trend
Computed from daily close history using EMA cross, slope, and RSI signals.
Note: intraday data is not stored locally. “Hourly” uses the most recent 10 daily candles as a short-term proxy.
Fundamental Growth Charts
No fundamental data available for this stock.
Interactive charts for Revenue, Net Income, EBITDA, Free Cash Flow, EPS, ROE, ROCE, Gross/Net/Operating Margin and more — switch metric and period using the dropdowns above. CAGR is computed across the displayed window (quarterly CAGR is annualised). Visual growth charts make it easy to spot multi-year compounding trends at a glance — far faster than reading raw numbers in a table.
PROS
- Healthy ROCE of 22.4%.
- Generates positive free cash flow.
- In a confirmed uptrend (50-DMA above 200-DMA).
CONS
No notable concerns flagged.
* The pros and cons are auto-generated from financial metrics.
Valuation
Growth (CAGR)
Profitability & Returns
Balance Sheet & Liquidity
Ownership
Financial Snapshot
Financial Statements Quarterly Results · Profit & Loss · Balance Sheet · Cash Flows · Ratios
Quarterly Results
Figures in USD.
| Metric | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|
| Revenue | - | 20.09B | 20.85B | 24.81B | 22.46B | 20.15B |
| Cost of Revenue | - | 10.05B | 10.12B | 11.75B | 10.88B | 9.70B |
| Gross Profit | - | 10.04B | 10.73B | 13.06B | 11.58B | 10.45B |
| Operating Expenses | - | 5.67B | 5.46B | 5.66B | 5.71B | 5.69B |
| Operating Income | - | 4.37B | 5.27B | 7.39B | 5.87B | 4.76B |
| EBITDA | - | 5.63B | 7.53B | 8.60B | 7.15B | 6.41B |
| Interest Expense | - | 504.90M | 719.72M | 846.76M | 615.67M | 539.60M |
| Pretax Income | - | 3.42B | 5.21B | 5.93B | 4.93B | 4.34B |
| Tax Provision | - | 629.10M | 350.17M | 1.40B | 1.05B | 864.50M |
| Net Income | - | 2.72B | 4.75B | 4.35B | 3.77B | 3.39B |
| Diluted EPS | - | 0.18 | 0.30 | 0.28 | 0.24 | 0.22 |
Profit & Loss (Annual)
Figures in USD.
| Metric | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|
| Revenue | - | 79.71B | 79.74B | 89.45B | 88.24B |
| Cost of Revenue | - | 40.42B | 39.29B | 43.62B | 42.86B |
| Gross Profit | - | 39.29B | 40.45B | 45.84B | 45.38B |
| Operating Expenses | - | 21.88B | 21.67B | 24.33B | 23.06B |
| Operating Income | - | 17.40B | 18.77B | 21.51B | 22.32B |
| EBITDA | - | 23.08B | 24.27B | 29.01B | 28.97B |
| Interest Expense | - | 2.89B | 2.82B | 2.40B | 2.72B |
| Pretax Income | - | 14.24B | 15.04B | 19.49B | 19.42B |
| Tax Provision | - | -655.60M | 75.50M | 4.64B | 3.43B |
| Net Income | - | 14.46B | 14.50B | 14.44B | 15.50B |
| Diluted EPS | - | 0.93 | 0.92 | 0.91 | 0.99 |
Balance Sheet (Annual)
Figures in USD.
| Metric | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|
| Total Assets | - | 137.96B | 132.64B | 162.51B | 145.09B |
| Current Assets | - | 37.82B | 36.56B | 54.16B | 43.88B |
| Cash & Equivalents | - | 14.93B | 16.06B | 28.60B | 18.64B |
| Inventory | - | 12.56B | 9.08B | 11.69B | 10.52B |
| Receivables | - | 5.35B | 5.74B | 6.27B | 6.35B |
| Total Liabilities | - | 54.63B | 52.50B | 62.93B | 56.31B |
| Current Liabilities | - | 40.54B | 41.01B | 49.39B | 45.60B |
| Long Term Debt | - | 454.30M | 391.00M | 324.00M | 256.90M |
| Total Debt | - | 3.85B | 3.50B | 3.45B | 3.39B |
| Total Equity | - | 81.96B | 78.97B | 98.64B | 87.91B |
| Shares Outstanding | - | 15.75B | 15.75B | 15.76B | 15.76B |
Cash Flows (Annual)
Figures in USD.
| Metric | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|
| Operating Cash Flow | - | 20.64B | 24.71B | 26.10B | 24.45B |
| Investing Cash Flow | - | -5.00B | -5.77B | -5.46B | -4.95B |
| Financing Cash Flow | - | -16.34B | -16.12B | -10.35B | -26.77B |
| Capital Expenditure | - | -6.53B | -6.00B | -4.75B | -4.59B |
| Free Cash Flow | - | 14.11B | 18.71B | 21.35B | 19.86B |
| Net Change in Cash | - | -699.90M | 2.83B | 10.28B | -7.27B |
Ratios (Annual)
Figures in %.
| Metric | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|
| Gross Margin % | - | 49.3% | 50.7% | 51.2% | 51.4% |
| Operating Margin % | - | 21.8% | 23.5% | 24.0% | 25.3% |
| Net Margin % | - | 18.1% | 18.2% | 16.1% | 17.6% |
| ROE % | - | 17.6% | 18.4% | 14.6% | 17.6% |
| ROCE % | - | 17.9% | 20.5% | 19.0% | 22.4% |
Analyst View
Analyst aggregate. Targets and ratings update periodically; not investment advice.
Latest News
Recent headlines for ABEV
Ambev (ABEV) Q2 2026 Earnings Call Transcript
Premium beer surged 20% as World Cup activation drove margin expansion.
Beer Dynasty Families Sell €731 Million Stake in AB InBev
(Bloomberg) -- Some of the historic family owners of Anheuser-Busch InBev sold a €731 million ($843 million) stake in the world’s largest brewer, after its shares surged at the start of this year. Most Read from BloombergTrump Says US to Ho…
Ambev SA (ABEV) (Q2 2026) Earnings Call Highlights: Strong Beer Growth and Digital Expansion ...
Ambev SA (ABEV) reports 6% revenue growth and 24% EPS surge in Q2 2026, driven by premium beer and BEES marketplace, despite Brazil NAB volume decline.
Ambev Q2 Earnings Call Highlights
Ambev (NYSE:ABEV) reported stronger second-quarter operating performance, led by beer-volume growth, revenue management and margin expansion, while continuing to invest in brand activations tied to the FIFA World Cup. Chief Executive Office…
CCU vs. ABEV: Which Stock Should Value Investors Buy Now?
CCU vs. ABEV: Which Stock Is the Better Value Option?
PepsiCo Q2 Earnings Beat on Volume Gains & International Strength
PEP beats on Q2 earnings on a rise in organic revenues, improved volumes and solid international growth, offsetting margin pressure and North America softness.
ABEV — Frequently Asked Questions
What is the current share price of ABEV?
As of 2026-08-05 17:25 PDT, ABEV trades at $3.03 on NASDAQ/NYSE. Its 52-week range is $2.10 to $3.42.
What is the market capitalisation of ABEV?
ABEV has a market capitalisation of $47.76B on NASDAQ/NYSE.
What is the P/E ratio of ABEV?
ABEV trades at a trailing price-to-earnings (P/E) ratio of 3.07. Its price-to-book (P/B) ratio is 0.54.
What is the return on equity (ROE) of ABEV?
ABEV has a return on equity (ROE) of 17.63%. Its return on capital employed (ROCE) is 22.44%.
Is ABEV a good stock to buy?
This page provides a data-driven analysis of ABEV, including valuation ratios, profitability, growth trends, auto-generated pros and cons, peer comparison and AI exposure. Review these fundamentals alongside your own research and risk tolerance. This is informational content, not investment advice.